Search

everythinglearnresearchcommunity

for

Search:↓

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Upadacitinib effectively treated severe hair loss in a child.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.